Product Information

DEPO-PROVERA 150 MG/ML VIAL is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $50.9940 per ML under NDC 00009074630. Its NADAC has been published 331 times since Apr 23, 2014.

FDA first approved this application on Oct 29, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the medroxyprogesterone acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for DEPO-PROVERA 150 MG/ML VIAL has been published 331 times since Apr 23, 2014, and over the history we have for it it has declined 56.9%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 64% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.